A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients

NCT02570854 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia, Iron-Deficiency

Interventions

BIOLOGICAL: CSJ137
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals